The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $338,440 in first-year total cost, median $169,220.
Most frequent study sections
- Career Development Study Section (J)[NCI-J]2
Most frequent institutions
- UNIVERSITY OF TEXAS MED BR GALVESTON1
- UNIVERSITY OF WISCONSIN-MADISON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Targeting Mesenchymal Stem Cells in Head and Neck Cancer1K08CA184915-01A1 | WATTS, TAMMARA L. | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $159,700 | NCI |
| 2014 | Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy1K08CA174750-01A1 | CAPITINI, CHRISTIAN | UNIVERSITY OF WISCONSIN-MADISON, WI | $178,740 | NCI |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.